Mike Mensinger

CIK: 0002048500

Transaction Breakdown

Open Market Buys (P)1 (4.3%)

High conviction signal

Open Market Sales (S)14 (60.9%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)6 (26.1%)

Compensation grants

Other (G, F, J, C, D, …)2 (8.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BBNX

Beta Bionics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (23 total)

BBNX
Beta Bionics, Inc.
Oct 27, 2026
Sale(S)
Direct
2.7K shares at avg. $22.00$58K
BBNX
Beta Bionics, Inc.
Sep 16, 2026
Sale(S)
Direct
2.7K shares at avg. $22.00$58K
BBNX
Beta Bionics, Inc.
Sep 2, 2026
Sale(S)
Direct
4.4K shares at avg. $19.11$84K
BBNX
Beta Bionics, Inc.
Jun 2, 2026
Sale(S)
Direct
4.4K shares at avg. $12.61$55K
BBNX
Beta Bionics, Inc.
Mar 2, 2026
Sale(S)
Direct
1.1K shares at avg. $12.36$13K
BBNX
Beta Bionics, Inc.
Feb 27, 2026
Award(A)
Employee Stock Option (right to buy)
Direct
91.5K shares-
BBNX
Beta Bionics, Inc.
Feb 27, 2026
Award(A)
Direct
109.1K shares-
BBNX
Beta Bionics, Inc.
Jan 6, 2026
Sale(S)
Direct
2.2K shares at avg. $30.10$66K
BBNX
Beta Bionics, Inc.
Jan 2, 2026
Sale(S)
Direct
7.2K shares at avg. $29.56$213K
BBNX
Beta Bionics, Inc.
Jan 2, 2026
Sale(S)
Direct
600 shares at avg. $30.20$18K
BBNX
Beta Bionics, Inc.
Dec 2, 2025
Sale(S)
Direct
1.1K shares at avg. $29.34$31K
BBNX
Beta Bionics, Inc.
Sep 2, 2025
Sale(S)
Direct
1.1K shares at avg. $18.86$21K
BBNX
Beta Bionics, Inc.
Jun 2, 2025
Sale(S)
Direct
101 shares at avg. $18.69$2K
BBNX
Beta Bionics, Inc.
Jun 2, 2025
Sale(S)
Direct
306 shares at avg. $17.03$5K
BBNX
Beta Bionics, Inc.
Jun 2, 2025
Sale(S)
Direct
708 shares at avg. $18.15$13K
BBNX
Beta Bionics, Inc.
Feb 27, 2025
Award(A)
Direct
35K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Sale(S)
Direct
13 shares at avg. $17.00$221
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Purchase(P)
Direct
33.4K shares at avg. $17.00$567K
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Conversion(C)
Direct
15.1K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
236.6K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
110.3K shares-
BBNX
Beta Bionics, Inc.
Jan 31, 2025
In-the-Money(X)
Direct
10.6K shares at avg. $0.02$211.5
BBNX
Beta Bionics, Inc.
Jan 29, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
110.3K shares-

		Type	Shares	Price		Ownership
Oct 27, 2026	BBNX Beta Bionics, Inc.	Sale(S)	2,650	$22.00	$58,300	Direct
Sep 16, 2026	BBNX Beta Bionics, Inc.	Sale(S)	2,650	$22.00	$58,300	Direct
Sep 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	4,375	$19.11	$83,620	Direct
Jun 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	4,378	$12.61	$55,194	Direct
Mar 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	1,064	$12.36	$13,153	Direct
Feb 27, 2026	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	91,520	-	-	Direct
Feb 27, 2026	BBNX Beta Bionics, Inc.	Award(A)	109,105	-	$0	Direct
Jan 6, 2026	BBNX Beta Bionics, Inc.	Sale(S)	2,200	$30.10	$66,221	Direct
Jan 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	7,200	$29.56	$212,832	Direct
Jan 2, 2026	BBNX Beta Bionics, Inc.	Sale(S)	600	$30.20	$18,118	Direct
Dec 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	1,063	$29.34	$31,184	Direct
Sep 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	1,089	$18.86	$20,542	Direct
Jun 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	101	$18.69	$1,888	Direct
Jun 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	306	$17.03	$5,211	Direct
Jun 2, 2025	BBNX Beta Bionics, Inc.	Sale(S)	708	$18.15	$12,849	Direct
Feb 27, 2025	BBNX Beta Bionics, Inc.	Award(A)	35,000	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Sale(S)	13	$17.00	$221	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Purchase(P)	33,350	$17.00	$566,950	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Conversion(C)	15,107	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	236,553	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	110,278	-	-	Direct
Jan 31, 2025	BBNX Beta Bionics, Inc.	In-the-Money(X)	10,575	$0.02	$212	Direct
Jan 29, 2025	BBNX Beta Bionics, Inc.	Award(A) Employee Stock Option (right to buy)	110,278	-	-	Direct

1-23 of 23 transactions

About Mensinger Mike

Mensinger Mike (SEC CIK 0002048500) files insider reports with the SEC as Chief Product Officer of Beta Bionics, Inc. (BBNX).

Signal8 holds 15 ownership filings by Mensinger Mike (1 Form 3, 14 Form 4), filed between Jan 29, 2025 and Oct 29, 2026. Those filings report 23 transactions, from Jan 29, 2025 to Oct 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Mensinger Mike's filings is in IRVINE, CA.

Recent filings by Mensinger Mike

Oct 27, 2026: Open-market sale of BBNX shares (Form 4, code S).
Sep 16, 2026: Open-market sale of BBNX shares (Form 4, code S).
Sep 2, 2026: Open-market sale of BBNX shares (Form 4, code S).
Jun 2, 2026: Open-market sale of BBNX shares (Form 4, code S).
Mar 2, 2026: Open-market sale of BBNX shares (Form 4, code S).

Other insiders filing for Beta Bionics, Inc. (BBNX)

Hopman Mark, Chief Commercial Officer
Jones Christy, Director
Saint Sean, President & CEO
Russell Steven Jon, Chief Medical Officer
Feider Stephen, Chief Financial Officer
MICHEL GERARD J, Director

How to read Form 4 transaction codes